Fundamentals for DaVita Inc.
Price projections for DVA have been revised upward over time, signaling increasing optimism about the company's future. This steady increase reflects a positive outlook for...
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Revenue projections:
Financial Ratios:
| currentRatio | 1.412000 |
|---|---|
| forwardPE | 10.314538 |
| debtToEquity | 1189.574000 |
| earningsGrowth | 0.667000 |
| revenueGrowth | 0.046000 |
| grossMargins | 0.322760 |
| operatingMargins | 0.151680 |
| trailingEps | 13.210000 |
| forwardEps | 16.876180 |
A current ratio of 1.412 for DVA implies that the company has ample liquidity to meet its short-term debts. DVA's cash reserves and current assets should easily cover these obligations, highlighting its financial stability and ability to manage short-term liabilities.
DaVita Inc.'s Forward PE is positioned well, reflecting a favorable balance between stock price and earnings. The stock isn't overpriced, offering room for growth and making it a potentially rewarding investment as its value has room to rise further.
DaVita Inc.'s elevated debt-to-equity ratio suggests the company is highly leveraged, meaning it has significant debt compared to equity. This can be risky, particularly if DaVita Inc.'s cash flow or profits decrease, making it harder to meet debt obligations.
DVA's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that DVA is likely to outperform its previous year's financial performance.
Price projections:
Insider Transactions:
11 DVA shares were sold in recent transactions, with market price at 183.57908977161753.No sell transactions took place in the period under consideration.DVA is seeing more buys than sells at current price levels, which may indicate a positive market outlook. This trend suggests growing confidence among investors, who appear to expect favorable performance from the stock.
Recommendation changes over time:
DaVita Inc. has faced a sell bias from analysts recently, indicating that caution is advised. Investors should expand their focus to a broader set of market indicators when making decisions, ensuring a well-rounded approach rather than acting solely on one piece of analysis.